Zobrazeno 1 - 10
of 27
pro vyhledávání: ''
Autor:
Robert, Benamouzig, Bernard, Uzzan, Jacques, Deyra, Antoine, Martin, Bernard, Girard, Julian, Little, Stanislas, Chaussade, E, Zafrani
Publikováno v:
Gut
Gut, 2012, 61 (2), pp.255-261. ⟨10.1136/gutjnl-2011-300113⟩
Gut, 2012, 61 (2), pp.255-261. ⟨10.1136/gutjnl-2011-300113⟩
International audience; Background Aspirin inhibits colorectal carcinogenesis. In a randomised double-blind placebo-controlled trial, daily soluble aspirin significantly reduced recurrence of colorectal adenomas at 1-year follow-up. In this study the
Autor:
Mark I. Hamilton, Georgios Kalambokis, Andrew K. Burroughs, Laura Marelli, Elias Xirouchakis, Evangelos Cholongitas
Publikováno v:
Gut. 60:1224-1228
BACKGROUND AND AIMS: Ulcerative colitis (UC) associated with primary sclerosing cholangitis (PSC) is usually clinically mild. The aim of the study was to assess whether there is an association between severity of PSC and activity of UC, comparing the
Publikováno v:
Gut. 40:344-349
BACKGROUND: Although sulindac is known to cause regression of colorectal adenomatous polyps in familial adenomatous polyposis, less is known about the effect of sulindac on sporadic adenomas. The precise mechanisms of these effects also remain to be
Publikováno v:
Gut. 65:A8.1-A8
Introduction The Composite Caecal Intubation Rate (CIR c ) has been proposed as a more pragmatic colonoscopy performance index, encompassing three key components; caecal intubation rate (CIR), patient comfort and sedation dose. 1 We calculated CIR c
Autor:
Roger C. Prudham, Atta M. Abbasi, Uche Nosegbe, Jimmy K. Limdi, R Butcher, Jennifer A. Scott, Regi George
Publikováno v:
Gut. 65:A263.3-A264
Introduction The UK Bowel Cancer Screening Programme (BCSP) launched in 2006, currently screens individuals aged 60–74 years through a Faecal Occult Blood test (FOBt). If positive patients are invited for colonoscopy. We reported in 2012 the first
Publikováno v:
Gut. 63:A48-A49
Introduction While oral anticoagulant therapy increases the possibility of bleeding, withholding it could cause thromboembolic complications. The BSG provides guidance regarding endoscopy and anticoagulation. Patients may be considered as having a hi
Publikováno v:
Gut. 64:A200.3-A201
Introduction Whilst colonoscopy is the only test offered within the BCSP after a positive faecal occult blood (FOB) result, there is often a dilemma whether to offer an alternative test in borderline cases especially now the CTC can be performed with
PTH-025 Which patients tolerate unsedated colonoscopy? a uk bowel cancer screening centre experience
Publikováno v:
Gut. 64:A416.2-A416
Introduction In the UK Bowel Cancer Screening Programme (BCSP), sedation doses and comfort scoring are used in quality assurance. There is debate whether we should offer unsedated colonoscopy, nitrous oxide being available in many units. This is a do
Publikováno v:
Gut. 52(4)
A 57 year old Caucasian man presented with an eight week history of loose bowel motions 10 times daily, with blood, slime, and mucus. Sigmoidoscopy showed an abnormal vascular pattern and a granular mucosa. Rectal biopsy was reported histologically t
Publikováno v:
Gut. 60:A44-A45
Introduction The principle indicator for assessing competence in colonoscopy is caecal intubation rate (CIR). Comfort is a key auditable outcome for colonoscopy but there are no standards for patient comfort during colonoscopy and no reports of comfo